A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2

Remarkable progress has been made in developing intramuscular vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); however, they are limited with respect to eliciting local immunity in the respiratory tract, which is the primary infection site for SARS-CoV-2. To overcome th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Junyu, Wang, Pui, Yuan, Lunzhi, Zhang, Liang, Zhang, Limin, Zhao, Hui, Chen, Congjie, Wang, Xijing, Han, Jinle, Chen, Yaode, Jia, Jizong, Lu, Zhen, Hong, Junping, Lu, Zicen, Wang, Qian, Chen, Rirong, Qi, Ruoyao, Ma, Jian, Zhou, Min, Yu, Huan, Zhuang, Chunlan, Liu, Xiaohui, Han, Qiangyuan, Wang, Guosong, Su, Yingying, Yuan, Quan, Cheng, Tong, Wu, Ting, Ye, Xiangzhong, Zhang, Tianying, Li, Changgui, Zhang, Jun, Zhu, Huachen, Chen, Yixin, Chen, Honglin, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press. Published by Elsevier B.V. and Science China Press. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134758/
https://www.ncbi.nlm.nih.gov/pubmed/35637645
http://dx.doi.org/10.1016/j.scib.2022.05.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134758/
https://www.ncbi.nlm.nih.gov/pubmed/35637645
http://dx.doi.org/10.1016/j.scib.2022.05.018

Ejemplares similares